Literature DB >> 2025526

Symptomatic cholelithiasis in pediatric renal transplant recipients.

M E Diaz-Gonzalez de Ferris1, S A Mendoza, W R Griswold, L H Strauch, V M Reznik.   

Abstract

We report two cases of symptomatic cholelithiasis in pediatric renal transplant recipients immunosuppressed with cyclosporine (CsA), prednisone and azathioprine. CsA was present in the bile and in the cholesterol gallstones of one patient. The diagnosis of cholelithiasis was established in both cases by abdominal ultrasound examination.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2025526     DOI： 10.1007/bf00852832

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  21 in total

Review 1.  Risk factors for the development of cholelithiasis in man (first of two parts).

Authors:  L J Bennion; S M Grundy
Journal:  N Engl J Med       Date:  1978-11-23       Impact factor: 91.245

2.  Alterations in cyclosporine pharmacokinetics after renal transplantation are linked to rapid increases in hematocrit, lipoproteins, and serum protein.

Authors:  B L Kasiske; W M Awni; K L Heim-Duthoy; M Rose; V K Rao; P Bloom; A Ney; J Andrisevic; M Odland; R C Andersen
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

Review 3.  Cholelithiasis in infants, children, and adolescents.

Authors:  G W Holcomb; G W Holcomb
Journal:  Pediatr Rev       Date:  1990-03

Review 4.  Pathogenesis of cholesterol gallstones.

Authors:  A F Hofmann
Journal:  J Clin Gastroenterol       Date:  1988       Impact factor: 3.062

5.  Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis.

Authors:  R C Stern; F C Rothstein; C F Doershuk
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986-01       Impact factor: 2.839

6.  Cyclosporin A hepatotoxicity in 66 renal allograft recipients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Transplantation       Date:  1981-12       Impact factor: 4.939

7.  The role of the gallbladder in the pathogenesis of cholesterol gallstones.

Authors:  W W LaMorte; D J Schoetz; D H Birkett; L F Williams
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

8.  Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients.

Authors:  M I Lorber; C T Van Buren; S M Flechner; C Williams; B D Kahan
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

9.  Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years.

Authors:  B D Kahan; S M Flechner; M I Lorber; D Golden; S Conley; C T Van Buren
Journal:  Transplantation       Date:  1987-02       Impact factor: 4.939

Review 10.  Biliary lipid composition in patients with cystic fibrosis.

Authors:  M Becker; D Staab; O Leiss; K von Bergmann
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-04       Impact factor: 2.839
View more
  1 in total

1.  Pediatric renal transplantation in Laurence-Moon-Biedl syndrome.

Authors:  C M Collins; S A Mendoza; W R Griswold; D Tanney; E Lieberman; V M Reznik
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.